Strategic

Sarstedt acquires FaCellitate

Surface solutions for 3D cell culture · Mannheim, Germany

SourcingClub was not involved in this transaction.

Sarstedt acquires FaCellitate from Mannheim, expanding its life science portfolio with solutions for 3D cell culture. FaCellitate develops polymer-based surfaces for cell culture that are used in research, drug development and toxicology.

Deal-Radar editorial team · responsible:

Source from the same day: chemanager-online.com , 16 Nov 2026

Who was involved.

Buyer
Sarstedt
Target
FaCellitate, Mannheim
Type
Strategic
Sector
Surface solutions for 3D cell culture
Country
Germany
Source dated
16/11/2026

Deal-Radar no. 47-017 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits

We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.

November 2026 on the Deal-Radar.

79 of 190 deals so far are of the type Strategic.

  1. Strategic79
  2. Add-on32
  3. Carve-out23
  4. Funding round23
  5. Insolvency11
  6. Buy-out9
  7. Minority stake6
  8. Secondary5
  9. Merger1
  10. Succession1

New deals every day. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 16 November 2026.